(Q44870645)

7 December 2017

title

The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis (English)

1 reference

7 December 2017

0 references

1 reference

1 reference

1 reference

A A Pedro

1

1 reference

7 December 2017

T W Gehr

series ordinal

2

1 reference

7 December 2017

D F Brophy

series ordinal

3

1 reference

7 December 2017

D A Sica

series ordinal

4

1 reference

7 December 2017

publication date

1 April 2000

1 reference

The Journal of Clinical Pharmacology

7 December 2017

published in

1 reference

7 December 2017

volume

40

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

389-395

1 reference

Losartan: first of a new class of angiotensin antagonists for the management of hypertension

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in human hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

The pharmacokinetics of irbesartan in renal failure and maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Clinical pharmacology of multiple-dose losartan, an angiotensin II receptor antagonist, in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Human plasma protein binding of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) and its pharmacologically active metabolite EXP3174

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Evaluation of the Losartan in Hemodialysis (ELHE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Effect of acute and chronic losartan therapy on active and inactive renin and active renin glycoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

Interactions between the renin-angiotensin system (RAS) and the sympathetic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912700022009099

10.1177/00912700022009099

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference